Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$60.44 +0.57 (+0.95%)
As of: Sep 30, 2026 · 3:00 PM EDT

Biomarin Pharmaceutical (BMRN) Receivables - Other (2010 - 2012)

Updated

Biomarin Pharmaceutical (BMRN) recorded Receivables - Other of $9.02 million in Q3 2012, up 23.8% from $7.28 million a year earlier but down 7.8% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Receivables - Other (2010 - 2012) Analysis & Trends

At the end of FY2011, Biomarin Pharmaceutical reported Receivables - Other of $6.09 million, down 16.6% from FY2010.

  • Across earlier years, Receivables - Other came in at $7.31 million in FY2010.
  • Quarterly Receivables - Other has ranged from $4.61 million in Q2 2011 to $9.78 million in Q2 2012 over the past five years.
  • Per Business Quant, the preceding three quarters came in at $9.78 million (Q2 2012), $6.83 million (Q1 2012) and $6.09 million (Q4 2011).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn
10 Biomarin Pharmaceutical 11.59 Bn 5.45 Bn 786.91 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 9.02 Mn
Jun 30, 2012 9.78 Mn
Mar 31, 2012 6.83 Mn
Dec 31, 2011 6.09 Mn
Sep 30, 2011 7.28 Mn
Jun 30, 2011 4.61 Mn
Dec 31, 2010 7.31 Mn
API Access

Biomarin Pharmaceutical Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=BMRN&period=max&api_key=YOUR_API_KEY